中国性科学2024,Vol.33Issue(8) :62-65.DOI:10.3969/j.issn.1672-1993.2024.08.014

肿瘤干细胞在卵巢癌中的研究现状及进展

Research status and progress of cancer stem cells in ovarian cancer

薄文嘉 王雅楠 宋殿荣
中国性科学2024,Vol.33Issue(8) :62-65.DOI:10.3969/j.issn.1672-1993.2024.08.014

肿瘤干细胞在卵巢癌中的研究现状及进展

Research status and progress of cancer stem cells in ovarian cancer

薄文嘉 1王雅楠 2宋殿荣2
扫码查看

作者信息

  • 1. 天津中医药大学,天津 300000
  • 2. 天津中医药大学第二附属医院妇科,天津 300000
  • 折叠

摘要

肿瘤干细胞是恶性肿瘤发生、耐药、复发及转移的根源,并最终导致恶性肿瘤治疗失败.卵巢癌干细胞的研究有助于进一步了解卵巢癌的发病机制,同时对解决卵巢癌高耐药、高复发转移的难题有重要意义.本文从肿瘤干细胞的基本概况、卵巢癌干细胞与卵巢癌发展的关系以及对卵巢癌干细胞的靶向治疗这三个方面进行相关综述.

Abstract

Cancer stem cells are the root cause of the occurrence,drug resistance,recurrence,and metastasis of malignant tumors,and ultimately lead to treatment failure of malignant tumors.The study of ovarian cancer stem cells contributes to further understanding the pathogenesis of ovarian cancer,and is of great significance in solving the problem of high drug resistance,high recurrence and metastasis of ovarian cancer.This article reviews the basic situation of tumor stem cells,the relationship between ovarian cancer stem cells and the development of ovarian cancer,and the targeted treatment of ovarian cancer stem cells.

关键词

肿瘤干细胞/卵巢癌/耐药/复发及转移/靶向治疗

Key words

Ovarian cancer stem cells/Ovarian cancer/Drug resistance/Recurrence and metastasis/Targeted therapy

引用本文复制引用

基金项目

天津市教委科研项目(2021KJ166)

出版年

2024
中国性科学
中国性学会

中国性科学

CSTPCD
影响因子:1.394
ISSN:1672-1993
段落导航相关论文